While we used only DBA/2CrSlc strain to evaluate the effects of SYK inhibitors on muscle activity, we consider that this strain may be a suitable model for evaluating the impact of SYK inhibitors in muscles because the strain background primarily exhibits susceptibility to muscular dystrophy and fibrosis. This evidence concerns the gene SYK and muscular dystrophy.